Answers are grounded in this paper and cite their sources.
Although the initial specimen diversion device (ISDD) has been shown to reduce blood culture contamination (BCC) rates, its impact on clinical outcomes remains unclear. This multicenter study showed that ISDD significantly decreased BCC. However, there was no reduction in length of stay, days of therapy, or central line-associated bloodstream infections.
No takes yet. Share an insight, caveat, or question.
Febres-Aldana et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: